Turmeric, a rhizome commonly referred to as a root, contains Curcumin, a potent antioxidant renowned for its remarkable anti-inflammatory properties. Our groundbreaking formulation utilizes the world's FIRST turmeric variety to demonstrate clinical bioequivalence at a low dosage. But what does bioequivalence entail? Essentially, it signifies that two or more products are equivalent in producing a specific effect. To illustrate, JAKA's 300mg turmeric dosage delivers an equivalent amount of curcuminoids as a highly effective high dosage found in industry standards.